Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hardman & Co call the lithium market: is a change in trend happening?
Tower Resources identify 18 million barrels of contingent reserves worth $118M in Cameroon




Share Price Information for Hikma (HIK)


Share Price: 1,843.50Bid: 1,832.00Ask: 1,833.50Change: 0.00 (0.00%)No Movement on Hikma
Spread: 1.50Spread as %: 0.08%Open: 1,770.50High: 1,854.50Low: 1,770.50Yesterday’s Close: 1,843.50

Hikma Pharmaceuticals Plc Ord Shs 10P

Hikma is listed in the FTSE 250, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Hikma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
1843.50
Share Price SpacerBid
1832.00
Share Price SpacerAsk
1833.50
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
660,198
Share Price SpacerOpen
1,770.50
Share Price SpacerHigh
1,854.50
Share Price SpacerLow
1,770.50
Share Price SpacerClose
1,843.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 241.45m £4,451.04m 1,000

52 Week High 2,089.00 52 Week High Date 8-NOV-2018
52 Week Low 814.20 52 Week Low Date 1-MAR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2,427 188,154 314,270 -7.053 -261.39 25.45 1.38


London South East Users info for Hikma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

14-Dec-18
17:07:35
1,843.50
7,815
Buy* 
1,832.00
1,833.50
144.07k
Trade Type:
Ordinary
Delayed publication

14-Dec-18
16:49:52
1,843.332
214
Buy* 
1,832.00
1,833.50
3,945
Trade Type:
Ordinary
Delayed publication

14-Dec-18
17:37:54
1,842.44
10,249
Buy* 
1,832.00
1,833.50
188.83k
Trade Type:
Ordinary




View more Hikma trades >>

Directors Deals for Hikma (HIK)
Trade DateActionNotifierPriceCurrencyAmountHolding
12-Jun-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Khalid Nabilsi held the position of CFO at Hikma Pharmaceuticals at the time of this trade.
 Khalid Nabilsi
012,842209700
30-May-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Said Darwazah held the position of Chairman and CEO at Hikma Pharmaceuticals at the time of this trade.
 Said Darwazah
052,16414956362
30-May-17Transfer From
Trade Notifier Information for Hikma Pharmaceuticals
Mazen Darwazah held the position of Executive Vice Chairman at Hikma Pharmaceuticals at the time of this trade.
 Mazen Darwazah
038,0883412058
View more Hikma directors dealings >>


Sister8
Posts: 164
Opinion:No Opinion
Price:1,779.50
RE: 2nd Time Lucky long @ 1675p again
28 Nov '18
cashed out for a quick 7% in a week........a bank in Gibralter only pays 3% pa!!!!

Thanks again Hikma and do please re visit 1675p again as it must be my lucky number )

S8
Sister8
Posts: 164
Opinion:No Opinion
Price:1,659.50
RE: 2nd Time Lucky long @ 1675p again
21 Nov '18
of course just to prove a point the market moves against me......still, I guess if we all got it right from the fiirst purchase the industry wouldnt make money!!

I am adding here.

Good luck

S8
Pianista
Posts: 293
Opinion:No Opinion
Price:1,654.00
RE: 2nd Time Lucky long @ 1675p again
20 Nov '18
I think you will. GL.
Sister8
Posts: 164
Opinion:No Opinion
Price:1,654.00
2nd Time Lucky long @ 1675p again
20 Nov '18
lets see if the magic repeats itself and I get another 15% for the Santa fund )

Good luck.

S8
Pianista
Posts: 293
Opinion:No Opinion
Price:1,688.00
Odd reaction to great results
19 Nov '18
Following great results, briefly touched £21, in line with broker target prices, before dropping like a stone to less than £17 today. Would have been better to have kept its mouth shut!
View more share chat for Hikma (HIK) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.